BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10071018)

  • 1. Effect of systemic cyclosporine on tumor recurrence after liver transplantation in a model of hepatocellular carcinoma.
    Freise CE; Ferrell L; Liu T; Ascher NL; Roberts JP
    Transplantation; 1999 Feb; 67(4):510-3. PubMed ID: 10071018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver transplantation improves survival of rats bearing hepatoma-3924A.
    Roberts JP; Liu T; Freise CE; Mielczarek J; Ferrell L; Randall H; Ascher NL
    J Surg Res; 1996 Sep; 65(1):59-62. PubMed ID: 8895607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of immunosuppression in recurrence after liver transplantation for diethylnitrosamine-induced tumors in rats.
    Ceriello A; Mezza F; Cozzolino S; Pettinato G; Mancini A; Santaniello W; Calise F; Cuomo O
    Transpl Int; 1994; 7 Suppl 1():S204-7. PubMed ID: 11271203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatotoxins and liver transplantation decrease pulmonary metastases in rats with hepatoma.
    Freise CE; Liu T; Ascher NL; Roberts JP
    J Surg Res; 1996 Aug; 64(2):198-202. PubMed ID: 8812633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sorafenib delays recurrence and metastasis after liver transplantation in a rat model of hepatocellular carcinoma with high expression of phosphorylated extracellular signal-regulated kinase.
    Yan J; Tan C; Gu F; Jiang J; Xu M; Huang X; Dai Z; Wang Z; Fan J; Zhou J
    Liver Transpl; 2013 May; 19(5):507-20. PubMed ID: 23408515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence.
    Vivarelli M; Cucchetti A; La Barba G; Ravaioli M; Del Gaudio M; Lauro A; Grazi GL; Pinna AD
    Ann Surg; 2008 Nov; 248(5):857-62. PubMed ID: 18948815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic resection enhances growth of residual intrahepatic and subcutaneous hepatoma, which is inhibited by octreotide.
    Schindel DT; Grosfeld JL
    J Pediatr Surg; 1997 Jul; 32(7):995-7; discussion 997-8. PubMed ID: 9247220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: key role of immunosuppression.
    Vivarelli M; Cucchetti A; Piscaglia F; La Barba G; Bolondi L; Cavallari A; Pinna AD
    Liver Transpl; 2005 May; 11(5):497-503. PubMed ID: 15838913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Everolimus-based immunosuppression in patients with hepatocellular carcinoma at high risk of recurrence after liver transplantation: a case series.
    Ferreiro AO; Vazquez-Millán MA; López FS; Gutiérrez MG; Diaz SP; Patiño MJ
    Transplant Proc; 2014 Dec; 46(10):3496-501. PubMed ID: 25498079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of laparoscopic versus conventional technique in colonic and liver resection in a tumor-bearing small animal model.
    Kuntz C; Kienle P; Schmeding M; Benner A; Autschbach F; Schwalbach P
    Surg Endosc; 2002 Aug; 16(8):1175-81. PubMed ID: 12189479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental liver cancer: improved response after hepatic artery ligation and infusion of tumor necrosis factor-alpha and interferon-gamma.
    Yang R; Liu Q; Rescorla FJ; Grosfeld JL
    Surgery; 1995 Oct; 118(4):768-72; discussion 772-4. PubMed ID: 7570335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a rat model for orthotopic liver transplantation for hepatocellular carcinoma.
    Yano K; Fukuda Y; Sumimoto R; Ito H; Asahara T; Dohi K
    Surgery; 1995 Sep; 118(3):539-46. PubMed ID: 7652691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low recurrence rate of hepatocellular carcinoma after liver transplantation: better patient selection or lower immunosuppression?
    Vivarelli M; Bellusci R; Cucchetti A; Cavrini G; De Ruvo N; Aden AA; La Barba G; Brillanti S; Cavallari A
    Transplantation; 2002 Dec; 74(12):1746-51. PubMed ID: 12499891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A short course of cyclosporine immunosuppression inhibits rejection but not tolerance of rat liver allografts.
    Huang WH; Yan Y; De Boer B; Bishop GA; House AK
    Transplantation; 2003 Feb; 75(3):368-74. PubMed ID: 12589161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Early Initiated Everolimus on the Recurrence of Hepatocellular Carcinoma After Liver Transplantation.
    Rodríguez-Perálvarez M; Guerrero M; Barrera L; Ferrín G; Álamo JM; Ayllón MD; Artacho GS; Montero JL; Briceño J; Bernal C; Padillo J; Marín-Gómez LM; Pascasio JM; Poyato A; Gómez-Bravo MA; De la Mata M
    Transplantation; 2018 Dec; 102(12):2056-2064. PubMed ID: 29757893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of long-term immunosuppression for limb transplantation using cyclosporine, tacrolimus, and mycophenolate mofetil: implications for clinical composite tissue transplantation.
    Jones NF; Hebebrand D; Buttemeyer R; Zhao M; Benhaim P; Rao U
    Plast Reconstr Surg; 2001 Mar; 107(3):777-84. PubMed ID: 11304605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The significance and expresssion of fractalkine in acute rejection after rat orthotopic liver transplantation].
    Meng K; Song Z; Zhou X
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 May; 21(5):528-31. PubMed ID: 17578296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orthotopic liver transplantation for hepatitis C: outcome, effect of immunosuppression, and causes of retransplantation during an 8-year single-center experience.
    Ghobrial RM; Farmer DG; Baquerizo A; Colquhoun S; Rosen HR; Yersiz H; Markmann JF; Drazan KE; Holt C; Imagawa D; Goldstein LI; Martin P; Busuttil RW
    Ann Surg; 1999 Jun; 229(6):824-31; discussion 831-3. PubMed ID: 10363896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental thermoradiotherapy in malignant hepatocellular carcinoma.
    Hehr T; Budach W; Lamprecht U; Belka C; Classen J; Trübenbach J; Wehrmann M; Dietz K; Bamberg M
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1374-80. PubMed ID: 12654450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of hepatocellular carcinoma by transfecting interleukin-12 and interleukin-2 fusion gene intrasplenically, an experimental study].
    Yang JH; Fan RF; Qian QJ; You TG; Xue HB; Su CQ; Cao HF; Wu MC
    Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):740-3. PubMed ID: 12899748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.